Position in PCVX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$15,964,823
-$2,209,776 QoQ
Shares Held
274,640
-12.2% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#65
of 329 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. PCVX ranks #17 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in PCVX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,964,823 | 274,640 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $18,174,599 | 312,762 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $16,782,686 | 363,734 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $14,353,249 | 398,480 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $17,548,377 | 539,784 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $11,463,784 | 303,596 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $27,321,266 | 333,756 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $41,840,646 | 366,156 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $23,591,287 | 312,426 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $19,214,783 | 281,288 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $10,489,860 | 167,036 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $7,705,423 | 151,146 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $4,446,907 | 89,045 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $719,616 | 19,200 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $650,010 | 13,556 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||